For the fifth consecutive year, Horus Pharma is partnering with the French Society of Ophthalmology (SFO) to recognize projects led by young ophthalmologists that bridge the gap between research, innovation, and more sustainable ophthalmological practice.

 A long-term partnership

At the 2026 SFO Congress, two awards were presented by Martine Claret, President of Horus Pharma, and Marwan Sahyoun, Medical Director, alongside Prof. Carl Arndt and Dr. Laurence Desjardins, representatives of the French Society of Ophthalmology:

  • Lucas Sejournet (Lyon University Hospital), winner of the Ophthalmology Research and Innovation Award, for his project “Efficacy of anti-Staphylococcus aureus bacteriophages in an in vitro model of endophthalmitis.”
  • Simon Brocquet-Lestrade (Bordeaux University Hospital), winner of the Eco’Ophtalmo Award for ecological initiatives in ophthalmology, for his project “Reusable 3D Support: Giving a Second Life to Non-Contact Disposable Lenses”

For Marwan Sahyoun, “This edition of the SFO Awards is particularly important to us. It reflects Horus Pharma’s commitment to supporting young ophthalmologists. What strikes us every year is the richness of the projects presented and their ability to tangibly advance the future of ophthalmology.”

Eco’Ophtalmo: supporting concrete and sustainable initiatives

Created in 2024 in partnership with Horus Pharma, the SFO Eco’Ophtalmo Initiative Award highlights projects that advance ophthalmology in a more sustainable way.

First prototypes designed and manufactured locally using 3D printing.

In 2026, the Eco’Ophtalmo Award was presented to Dr. Simon Brocquet-Lestrade for an innovative project to repurpose single-use non-contact lenses, commonly used in vitreoretinal surgery.

The idea: to give them a second life in clinical practice using a reusable 3D-printed holder designed to accommodate a lens in its center for use in fundus examinations.

This device is part of a broader effort to reduce medical waste in ophthalmology, particularly waste associated with single-use devices.
An initial trial, conducted within the ophthalmology department at Bordeaux University Hospital, has already recovered 102 lenses after surgery between October 2024 and February 2025, confirming the concrete potential of this recycling initiative.

The lens can be replaced in the event of optical deterioration without replacing the entire holder.

The developed device also has the advantage of being simple, reproducible, and inexpensive, with a support structure manufactured locally via 3D printing using a bio-based, biocompatible, and recyclable material. Ultimately, the project is intended for broader deployment in clinical practice, particularly in other ophthalmology departments.

Interviewed at the SFO conference, Dr. Brocquet-Lestrade discusses his project and its prospects in a short video:

Through these awards, Horus Pharma reaffirms its commitment to supporting young ophthalmologists and initiatives that help advance the field.
Research, innovation, and more responsible ophthalmology: all of these efforts are helping to shape the future of ophthalmology today.